LifeStance Health Group, Inc. Other General Expense
LifeStance Health Group, Inc. (LFST) reported Other General Expense of $212.29 million for the 3-month period ending 2024-09-30, per its 10-Q filed 2024-11-07.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OtherGeneralExpense · last filed 2024-11-07
- LifeStance Health Group, Inc. other general expense for the quarter ending 2024-09-30 was $212.29M, a 13.72% increase year-over-year.
- LifeStance Health Group, Inc. other general expense for the quarter ending 2024-06-30 was $214.53M, a 14.96% increase year-over-year.
- LifeStance Health Group, Inc. other general expense for the quarter ending 2024-03-31 was $205.71M, a 12.42% increase year-over-year.
- LifeStance Health Group, Inc. other general expense for the quarter ending 2023-12-31 was $197.29M, a 18.37% increase year-over-year.
- LifeStance Health Group, Inc. other general expense for fiscal 2023 was $753.57M, a 21.05% increase from fiscal 2022.
- LifeStance Health Group, Inc. other general expense for fiscal 2022 was $622.52M, a 33.59% increase from fiscal 2021.
- LifeStance Health Group, Inc. other general expense for fiscal 2021 was $466.00M.
- LifeStance Health Group, Inc. other general expense for fiscal 2019 was $150.12M.
| Period end | Other General Expense 1 month | Other General Expense 3 month | Other General Expense 4 month | Other General Expense 6 month | Other General Expense 9 month | Other General Expense 12 month |
|---|---|---|---|---|---|---|
| 2024-09-30 | $212.29M 10-Q · filed 2024-11-07 | $426.82M derived: sum of 2 quarters · filed 2024-11-07 | $632.53M 10-Q · filed 2024-11-07 | $829.82M derived: sum of 4 quarters · filed 2024-11-07 | ||
| 2024-06-30 | $214.53M 10-Q · filed 2024-08-08 | $420.24M 10-Q · filed 2024-08-08 | $617.52M derived: sum of 3 quarters · filed 2024-08-08 | $804.21M derived: sum of 4 quarters · filed 2024-11-07 | ||
| 2024-03-31 | $205.71M 10-Q · filed 2024-05-09 | $403.00M derived: sum of 2 quarters · filed 2024-05-09 | $589.69M derived: sum of 3 quarters · filed 2024-11-07 | $776.29M derived: sum of 4 quarters · filed 2024-11-07 | ||
| 2023-12-31 | $197.29M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $383.98M derived: sum of 2 quarters · filed 2024-11-07 | $570.58M derived: sum of 3 quarters · filed 2024-11-07 | $753.57M 10-K · filed 2024-02-28 | ||
| 2023-09-30 | $186.69M 10-Q · filed 2024-11-07 | $373.29M derived: sum of 2 quarters · filed 2024-11-07 | $556.28M 10-Q · filed 2024-11-07 | $722.95M derived: sum of 4 quarters · filed 2024-11-07 | ||
| 2023-06-30 | $186.61M 10-Q · filed 2024-08-08 | $369.59M 10-Q · filed 2024-08-08 | $536.26M derived: sum of 3 quarters · filed 2024-08-08 | $693.53M derived: sum of 4 quarters · filed 2024-08-08 | ||
| 2023-03-31 | $182.99M 10-Q · filed 2024-05-09 | $349.65M derived: sum of 2 quarters · filed 2024-05-09 | $506.92M derived: sum of 3 quarters · filed 2024-05-09 | $656.62M derived: sum of 4 quarters · filed 2024-05-09 | ||
| 2022-12-31 | $166.67M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $323.94M derived: sum of 2 quarters · filed 2024-02-28 | $473.63M derived: sum of 3 quarters · filed 2024-02-28 | $622.52M 10-K · filed 2024-02-28 | ||
| 2022-09-30 | $157.27M 10-Q · filed 2023-11-08 | $306.96M derived: sum of 2 quarters · filed 2023-11-08 | $455.86M 10-Q · filed 2023-11-08 | $591.60M derived: sum of 4 quarters · filed 2024-02-28 | ||
| 2022-06-30 | $149.70M 10-Q · filed 2023-08-09 | $298.59M 10-Q · filed 2023-08-09 | $434.33M derived: sum of 3 quarters · filed 2024-02-28 | $556.12M derived: sum of 4 quarters · filed 2024-02-28 | ||
| 2022-03-31 | $148.89M 10-Q · filed 2023-05-10 | $284.64M derived: sum of 2 quarters · filed 2024-02-28 | $406.42M derived: sum of 3 quarters · filed 2024-02-28 | $515.76M derived: sum of 4 quarters · filed 2024-02-28 | ||
| 2021-12-31 | $135.75M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $257.53M derived: sum of 2 quarters · filed 2024-02-28 | $366.87M derived: sum of 3 quarters · filed 2024-02-28 | $466.00M 10-K · filed 2024-02-28 | ||
| 2021-09-30 | $121.78M 10-Q · filed 2022-11-09 | $231.12M derived: sum of 2 quarters · filed 2022-11-09 | $330.26M 10-Q · filed 2022-11-09 | $409.40M derived: sum of 4 quarters · filed 2023-03-09 | ||
| 2021-06-30 | $109.34M 10-Q · filed 2022-08-10 | $208.47M 10-Q · filed 2022-08-10 | $287.62M derived: sum of 3 quarters · filed 2023-03-09 | $356.46M derived: sum of 4 quarters · filed 2023-03-09 | ||
| 2021-03-31 | $99.13M 10-Q · filed 2022-05-11 | $178.28M derived: sum of 2 quarters · filed 2023-03-09 | $247.12M derived: sum of 3 quarters · filed 2023-03-09 | $278.40M derived: sum of 4 quarters · filed 2023-03-09 | ||
| 2020-12-31 | $79.14M derived: 10-K 9 month − 10-Q 6 month · filed 2023-03-09 | $147.99M derived: sum of 2 quarters · filed 2023-03-09 | $179.26M 10-K · filed 2023-03-09 | |||
| 2020-09-30 | $68.85M 10-Q · filed 2021-11-10 | $100.12M 10-Q · filed 2021-11-10 | ||||
| 2020-06-30 | $31.27M 10-Q · filed 2021-08-12 | |||||
| 2020-05-14 | $27.14M 10-Q · filed 2021-08-12 | $78.78M 10-K · filed 2023-03-09 | ||||
| 2019-12-31 | $150.12M 10-K · filed 2022-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B |